$ Value
$514K
Shares
3,517
Price
$146
Filed
Dec 16
Insider
Name
EDGEMOND JAMES
Title
CFO AND TREASURER
CIK
0001636178
Roles
Transaction Details
Transaction Date
2025-12-15
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
11,659
Footnotes
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 5, 2025. | The amount of common stock beneficially owned by the Reporting Person in the Reporting Person's Form 4s filed November 5, 12 and 18, 2025 did not include 24 shares acquired by the Reporting Person on September 4, 2025 under the United Therapeutics Corporation Stock Purchase Plan, which error caused the reporting person's common stock ownership to be underreported by 24 shares on such Form 4s. The amount of common stock beneficially owned by the Reporting Person in this Form 4 includes such shares. | This transaction was executed in multiple trades at prices ranging from $491.19 to $491.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $492.28 to $493.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $493.35 to $494.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $494.52 to $495.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $495.52 to $496.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $496.59 to $497.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $497.60 to $498.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $498.88 to $499.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $499.92 to $500.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Filing Info
EDGEMOND JAMES's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-20 | UTHR | M | $1.4M |
| 2026-04-20 | UTHR | ▼ | $504K |
| 2026-04-20 | UTHR | ▼ | $885K |
| 2026-04-20 | UTHR | ▼ | $254K |
| 2026-04-20 | UTHR | ▼ | $581K |
| 2026-04-20 | UTHR | ▼ | $806K |
| 2026-04-20 | UTHR | ▼ | $397K |
| 2026-04-20 | UTHR | ▼ | $289K |
| 2026-04-20 | UTHR | ▼ | $197K |
| 2026-04-20 | UTHR | ▼ | $284K |
Other Insiders at UTHR (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
ROTHBLATT MARTINE A
Chairperson & CEO
|
— | $193.8M | 2026-04-22 |
| KURZWEIL RAY | — | $2.4M | 2026-03-04 |
| PATUSKY CHRISTOPHER | — | $579K | 2026-04-17 |
|
MAHON PAUL A
EVP & GENERAL COUNSEL
|
— | $25.9M | 2026-04-16 |
| CAUSEY CHRISTOPHER | — | $1.3M | 2026-03-30 |
| Thompson Tommy G | — | $2.1M | 2026-03-26 |
| Olian Judy D. | — | $417K | 2026-03-23 |
|
EDGEMOND JAMES
CFO AND TREASURER
|
— | $50.8M | 2026-04-20 |
|
BENKOWITZ MICHAEL
PRESIDENT AND COO
|
— | $60.0M | 2026-03-15 |
| MALCOLM JAN | — | $97K | 2026-03-17 |